HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Endocrine System Diseases (Endocrine Diseases)

Subscribe to New Research on Endocrine System Diseases

Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES.

Also Known As:

Endocrine Diseases; Disease, Endocrine; Endocrine Disease; Diseases of Endocrine System; Disease, Endocrine System; Diseases, Endocrine; Diseases, Endocrine System; Endocrine System Disease; System Disease, Endocrine; System Diseases, Endocrine

Networked: 504 relevant articles (5 outcomes, 43 trials/studies)

Relationship Network

Disease Context: Research Results

Endocrine System Diseases: 504

Related Diseases

1.	Autoimmune Diseases (Autoimmune Disease)
2.	Neoplasms (Cancer)
3.	Endocrine System Diseases (Endocrine Diseases)
4.	Liver Cirrhosis (Hepatic Cirrhosis)
5.	Cardiovascular Diseases (Cardiovascular Disease)

Experts

1.	Gut, Paweł: 3 articles (01/2014 - 05/2007)
2.	Ziemnicka, Katarzyna: 3 articles (01/2014 - 05/2007)
3.	Morley, John E: 3 articles (02/2010 - 07/2003)
4.	Romijn, J A: 3 articles (10/2008 - 02/2001)
5.	Bellastella, Antonio: 3 articles (07/2005 - 02/2003)
6.	De Bellis, Annamaria: 3 articles (07/2005 - 02/2003)
7.	Bizzarro, Antonio: 3 articles (07/2005 - 02/2003)
8.	Sitges-Serra, Antonio: 2 articles (12/2015 - 08/2015)
9.	Pietrangelo, Antonello: 2 articles (10/2015 - 08/2010)
10.	Muscogiuri, G: 2 articles (04/2015 - 03/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Endocrine System Diseases:

1.	VaccinesIBA 01/01/2011 - "If this approach were found to be effective for reprogramming immunological tolerance in T1D, it could pave the way for the design of negative self-vaccines against autoimmune endocrine diseases, as well as other organ-specific autoimmune diseases." 08/01/2010 - "If this approach were found to be effective for reprograming immunological tolerance in T1D, it could pave the way for the design of other self-vaccines against autoimmune endocrine diseases, as well as other organ-specific autoimmune diseases."
2.	Ramipril (Altace)FDA LinkGeneric 11/01/2009 - "In our study, we showed that ramipril is effective in preventing AF relapses in patients with lone AF (LAF: i.e AF in the absence of clinical and echocardiographic evidence of cardiovascular, pulmonary, or endocrine disease), independently of any sizeable effect on cardiac echocardiographic anatomy when compared with baseline data. "
3.	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/01/2003 - "Somatostatin analogs: status of the art and perspectives in the treatment of endocrine and non endocrine diseases. " 09/01/1980 - "The mean CSF somatostatin level in twenty patients without endocrine disease was 76 pg/ml (range 46-112) which did not differ significantly from that found in eight acromegalics (mean 87 pg/ml, range 48-160). " 01/01/2004 - "The development of somatostatin analogues helped define its usefulness in the treatment of endocrine diseases and cancer. " 09/01/1980 - "Cerebrospinal fluid (CSF) and plasma levels of somatostatin have been measured in patients with active acromegaly and the results compared to those obtained in patients with non-endocrine diseases. " 01/01/2012 - "Activation of somatostatin receptors (sstr1-5) by somatostatin and its analogues exerts an inhibitory effect on hormone secretion and provides the basis for the treatment of a range of endocrine diseases such as acromegaly, Cushing's disease and neuroendocrine tumors (NET). "
4.	EnzymesIBA 01/01/2005 - "The procedure is very useful in the diagnosis of different endocrine diseases and in the recognition of dysfunction or absence of enzymes with an important role in steroid metabolism, and it gives possibility to control the treatment in patients with these diseases. " 01/01/1994 - "Defects in the encoding gene have been confirmed as the basis of endocrine disease in the case of all but one of the adrenal steroidogenic enzymes. " 10/21/2015 - "It is therefore essential to remember, when discovering altered liver enzymes or hepatic steatosis on radiological exams, that endocrine diseases can cause NAFLD. " 01/01/1993 - "Mutations in the encoding gene have been confirmed as the basis of endocrine disease in the case of all of the adrenal steroidogenic enzymes required for synthesis of cortisol but one (cholesterol desmolase). "
5.	HormonesIBA 12/01/2015 - "To enhance the accurate diagnosis and treatment of patients with hereditary endocrine diseases, we propose categorization of endocrine diseases into three groups based upon the function of the mutant gene: cell differentiation, hormone synthesis and action, and tumorigenesis. " 06/01/2015 - "We argue that astrocytes are key mediators of hormone actions on development of the cerebral cortex and cerebellum and that the identification of the molecules and pathways involved in these events might be important for determining the molecular-level basis of the neural deficits associated with endocrine diseases. " 01/01/2015 - "Hormone replacement strategies in adult endocrine disease." 02/01/2010 - "This article highlights the hormonal changes that occur with aging and the effects of these hormonal changes on the brain, concentrating not on the well-known psychiatric manifestations of endocrine diseases, but on the more subtle effects of hormones and metabolic alteration seen in many older persons. " 09/01/2009 - "Abnormalities in steroid hormones are responsible for the development and prevention of endocrine diseases. "
6.	AutoantibodiesIBA 03/01/2012 - "The reactivity against TPIT was not specific for lymphocytic hypophysitis with autoantibodies detectable in the sera from patients with other autoimmune endocrine diseases. " 02/01/2006 - "Frequency of diabetes and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon." 01/01/2001 - "In type 1 diabetes the coexistence with other endocrine diseases and organ-specific autoantibodies has been frequently reported leading to the concept of autoimmune polyendocrine syndrome (APS). " 06/01/1998 - "Since organ specific autoantibodies are frequent in patients with autoimmune endocrine disease as well as in their unaffected relatives, autoantibodies to this M(r) 49,000 pituitary cytosolic protein may represent markers for an immunological process affecting the pituitary gland." 09/01/1997 - "Increased prevalence of thyroid autoantibodies and subclinical thyroid failure in relatives of patients with overt endocrine disease-associated diabetes but not type 1 diabetes alone."
7.	NormetanephrineIBA 10/01/1968 - "Clinical studies on urinary metanephrine and normetanephrine in various endocrine diseases. " 09/01/1968 - "[Clinical studies on urinary metanephrine and normetanephrine in various endocrine diseases. " 09/01/1968 - "[Clinical studies on urinary metanephrine and normetanephrine in various endocrine diseases. "
8.	MetanephrineIBA 10/01/1968 - "Clinical studies on urinary metanephrine and normetanephrine in various endocrine diseases. " 09/01/1968 - "[Clinical studies on urinary metanephrine and normetanephrine in various endocrine diseases. " 09/01/1968 - "[Clinical studies on urinary metanephrine and normetanephrine in various endocrine diseases. "
9.	CatecholaminesIBA 06/01/1965 - "[Clinical studies on urinary catecholamines in various endocrine diseases. " 05/01/1965 - "[CLINICAL STUDIES ON URINARY CATECHOLAMINES IN VARIOUS ENDOCRINE DISEASES. " 05/01/1965 - "[CLINICAL STUDIES ON URINARY CATECHOLAMINES IN VARIOUS ENDOCRINE DISEASES. "
10.	GTP-Binding Proteins (G-Protein)IBA 12/01/2006 - "The study of mutations in G proteins and GPCRs has already had major implications for understanding the molecular basis of rare endocrine diseases, as well as susceptibility to multifactorial disorders that are associated with polymorphisms in these genes." 11/01/2001 - "This review summarizes the pathogenetic role of naturally occurring mutations of G protein genes in endocrine diseases. " 11/01/2001 - "G protein mutations in endocrine diseases." 05/01/1995 - "We have examined tissues from patients having more than one organ affected by an endocrine disorder and patients having separate distinct endocrine diseases for G protein gene mutations. " 12/01/1994 - "Also described are certain G-proteins as possible proto-oncogenes and how point mutations and frame shift mutations alter G-protein function and determine the characteristics of various endocrine diseases. "

Therapies and Procedures

1.	Bariatric Surgery 01/01/2011 - "The aim of this study was to evaluate the prevalence of common endocrine diseases in a series of obese patients scheduled for bariatric surgery. " 01/01/2016 - "MANAGEMENT OF ENDOCRINE DISEASE: Metabolic effects of bariatric surgery." 01/01/2011 - "Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes."
2.	Occupational Therapy (Therapy, Occupational) 02/01/2003 - "However, none of these three factors remained independently related to thyroid cancer after adjustment for other factors, which were significantly associated with thyroid cancer in the present study (history of residence in endemic goitre area, history of goitre or thyroid nodule, history of other endocrine diseases, radioactive iodine therapy, occupational exposure to various chemicals, family history of thyroid gland diseases and malignant tumours as well as intake of cruciferous vegetables and other vegetables, and consumption of smoked meat and cheese)."
3.	Immunotherapy 12/01/2010 - "Within this review, we present an overview on the role of all these cell populations in endocrine disease and the potential use of such cells for immunotherapy in different endocrine diseases and refer to experimental settings as well as clinical studies."
4.	Drug Therapy (Chemotherapy) 05/01/2006 - "The Panel recommended that patients be offered chemotherapy for endocrine non-responsive disease; endocrine therapy as the primary therapy for endocrine responsive disease, adding chemotherapy for some intermediate-and all high-risk groups in this category; and both chemotherapy and endocrine therapy for all patients in the uncertain endocrine response category except those in the low-risk group." 10/01/2005 - "The Panel recommended that patients be offered chemotherapy for endocrine non-responsive disease; endocrine therapy as the primary therapy for endocrine responsive disease, adding chemotherapy for some intermediate- and all high-risk groups in this category; and both chemotherapy and endocrine therapy for all patients in the uncertain endocrine response category except those in the low-risk group." 04/01/2012 - "Immune suppression due to endoparasitism or malnutrition in young dogs and endocrine diseases, neoplasia and chemotherapy in older dogs are considered predisposing factors and should be diagnosed and treated to optimize the therapeutic outcome. " 02/01/1995 - "In an attempt to avoid confounding factors as far as possible, we excluded patients who fulfilled any of the following criteria: age less than 18 or greater than 40 years; recent history of extended bed rest; previous diagnosis of metabolic bone disease, renal insufficiency, or hepatic failure; clinical or echographic signs of liver cirrhosis; diabetes mellitus or previous diagnosis of other endocrine diseases; drug therapy that could act on bone metabolism; and/or moderate to severe nutritional alteration. "
5.	Anesthesia 01/01/1997 - "Understanding the basic physiology of endocrinology and metabolism is important for the safe conduct of anesthesia of patients with endocrine disease. " 01/01/1980 - "Anesthesia and the patient with endocrine disease." 09/01/1973 - "[Panel discussion: anesthesia for patients with endocrine diseases. " 09/01/1973 - "[Panel discussion: anesthesia for patients with endocrine diseases. "